Lung Cancer
New lung cancer study findings recently were published by scientists in and the United States
Published in Oncology Business Week, December 31st, 2006
Study 1: Data detailed in "Beta-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor beta expression" have been presented. According to recent research from the United States, "Recent findings of an inverse association between beta-cryptoxanthin and lung cancer risk in several observational epidemiologic studies suggest that beta-cryptoxanthin could potentially act as a chemopreventive agent against lung cancer. However, the biological activity of beta-cryptoxanthin and molecular mechanism(s) by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Actinic Keratosis
Australian government approves registration of Solaraze 3% gel for carcinoma in situ - Awards
DxS receives Biotechnology Award for cancer product from BioNow - Breast Cancer
Study shows Confirma's CADstream may increase confidence in breast MRI interpretation - Breast Cancer Genetics
Research in the area of breast cancer genetics reported from Memorial Sloan Kettering Cancer Center - Breast Cancer Risk Factors
Recent findings in breast cancer risk factors described by investigators from Kaiser Permanente, Division of Research - Breast Cancer Screening
Reports from Siemens AG describe recent advances in breast cancer screening - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
